fig2
![Update on targeted therapy and immune therapy for gastric cancer, 2018](https://image.oaes.cc/3be17168-5502-4f6c-8118-a718fbdd8f1b/2638.fig.2.png)
Figure 2. Immune check point inhibitors in gastric cancer. CTLA-4: cytotoxic T-lymphocyte antige-4; MHC: major histocompatibility complex; PD-1: programmed death 1; PD-L1: programmed death-ligand 1; TCR: T cell receptor
Figure 2. Immune check point inhibitors in gastric cancer. CTLA-4: cytotoxic T-lymphocyte antige-4; MHC: major histocompatibility complex; PD-1: programmed death 1; PD-L1: programmed death-ligand 1; TCR: T cell receptor
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/